nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—PRDX5—Cellular responses to stress—CDKN2C—ocular cancer	0.0777	0.0777	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—H1F0—ocular cancer	0.073	0.073	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—E2F2—ocular cancer	0.0621	0.0621	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—E2F3—ocular cancer	0.0538	0.0538	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—RBBP4—ocular cancer	0.0538	0.0538	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—TFDP1—ocular cancer	0.05	0.05	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—CDK6—ocular cancer	0.0338	0.0338	CbGpPWpGaD
Auranofin—IKBKB—FoxO family signaling—RBL2—ocular cancer	0.028	0.028	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—CDKN2B—ocular cancer	0.0261	0.0261	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—E2F1—ocular cancer	0.0239	0.0239	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—CDK2—ocular cancer	0.0206	0.0206	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—CDK4—ocular cancer	0.0195	0.0195	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—RB1—ocular cancer	0.017	0.017	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—HDAC1—ocular cancer	0.0161	0.0161	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—CRTC1—ocular cancer	0.0161	0.0161	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—E2F3—ocular cancer	0.0153	0.0153	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—MDM2—ocular cancer	0.0145	0.0145	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—CDKN1B—ocular cancer	0.0132	0.0132	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—CDKN1A—ocular cancer	0.0122	0.0122	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—EP300—ocular cancer	0.0116	0.0116	CbGpPWpGaD
Auranofin—IKBKB—FoxO family signaling—CDK2—ocular cancer	0.0101	0.0101	CbGpPWpGaD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—HDAC1—ocular cancer	0.00945	0.00945	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—E2F1—ocular cancer	0.00893	0.00893	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—TP53—ocular cancer	0.00829	0.00829	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—CDK2—ocular cancer	0.00798	0.00798	CbGpPWpGaD
Auranofin—IKBKB—Validated transcriptional targets of TAp63 isoforms—MDM2—ocular cancer	0.00656	0.00656	CbGpPWpGaD
Auranofin—IKBKB—FoxO family signaling—CDKN1B—ocular cancer	0.00648	0.00648	CbGpPWpGaD
Auranofin—IKBKB—Estrogen signaling pathway—AKT1—ocular cancer	0.0063	0.0063	CbGpPWpGaD
Auranofin—IKBKB—FoxO family signaling—EP300—ocular cancer	0.00569	0.00569	CbGpPWpGaD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—MYC—ocular cancer	0.00561	0.00561	CbGpPWpGaD
Auranofin—IKBKB—Validated transcriptional targets of TAp63 isoforms—CDKN1A—ocular cancer	0.00553	0.00553	CbGpPWpGaD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—TGFB1—ocular cancer	0.00539	0.00539	CbGpPWpGaD
Auranofin—IKBKB—IL-4 Signaling Pathway—EP300—ocular cancer	0.00526	0.00526	CbGpPWpGaD
Auranofin—IKBKB—Validated transcriptional targets of TAp63 isoforms—EP300—ocular cancer	0.00526	0.00526	CbGpPWpGaD
Auranofin—IKBKB—IL17 signaling pathway—AKT1—ocular cancer	0.00496	0.00496	CbGpPWpGaD
Auranofin—IKBKB—GMCSF-mediated signaling events—HRAS—ocular cancer	0.00487	0.00487	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—MDM2—ocular cancer	0.00461	0.00461	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—TGFB1—ocular cancer	0.00451	0.00451	CbGpPWpGaD
Auranofin—IKBKB—FAS (CD95) signaling pathway—AKT1—ocular cancer	0.0045	0.0045	CbGpPWpGaD
Auranofin—IKBKB—Cytosolic sensors of pathogen-associated DNA—EP300—ocular cancer	0.00448	0.00448	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—CCND1—ocular cancer	0.0044	0.0044	CbGpPWpGaD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—HRAS—ocular cancer	0.00424	0.00424	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—AKT1—ocular cancer	0.00389	0.00389	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—MYC—ocular cancer	0.00386	0.00386	CbGpPWpGaD
Auranofin—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—EP300—ocular cancer	0.00384	0.00384	CbGpPWpGaD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—AKT1—ocular cancer	0.00375	0.00375	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—HRAS—ocular cancer	0.00366	0.00366	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—HDAC1—ocular cancer	0.00348	0.00348	CbGpPWpGaD
Auranofin—IKBKB—FoxO family signaling—AKT1—ocular cancer	0.00344	0.00344	CbGpPWpGaD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—HRAS—ocular cancer	0.00327	0.00327	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—AKT1—ocular cancer	0.00323	0.00323	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—MYC—ocular cancer	0.00322	0.00322	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—ocular cancer	0.00321	0.00321	CbGpPWpGaD
Auranofin—IKBKB—IL-4 Signaling Pathway—AKT1—ocular cancer	0.00318	0.00318	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—ocular cancer	0.00317	0.00317	CbGpPWpGaD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—AKT1—ocular cancer	0.00313	0.00313	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—AKT1—ocular cancer	0.00313	0.00313	CbGpPWpGaD
Auranofin—IKBKB—IL-1 signaling pathway—AKT1—ocular cancer	0.00313	0.00313	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—TP53—ocular cancer	0.0031	0.0031	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—HRAS—ocular cancer	0.00307	0.00307	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—HRAS—ocular cancer	0.00307	0.00307	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—TGFB1—ocular cancer	0.00304	0.00304	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—HRAS—ocular cancer	0.00303	0.00303	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—HRAS—ocular cancer	0.00303	0.00303	CbGpPWpGaD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—AKT1—ocular cancer	0.00289	0.00289	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—MYC—ocular cancer	0.00287	0.00287	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—HRAS—ocular cancer	0.00277	0.00277	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—AKT1—ocular cancer	0.00271	0.00271	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—AKT1—ocular cancer	0.00271	0.00271	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—AKT1—ocular cancer	0.00271	0.00271	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.0027	0.0027	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—AKT1—ocular cancer	0.00268	0.00268	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—AKT1—ocular cancer	0.00268	0.00268	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—MDM2—ocular cancer	0.00266	0.00266	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TP53—ocular cancer	0.00264	0.00264	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—AKT1—ocular cancer	0.00261	0.00261	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—MDM2—ocular cancer	0.00254	0.00254	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.00251	0.00251	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—TP53—ocular cancer	0.00248	0.00248	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—AKT1—ocular cancer	0.00245	0.00245	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—CDKN1B—ocular cancer	0.00243	0.00243	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—HRAS—ocular cancer	0.00239	0.00239	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—HRAS—ocular cancer	0.00235	0.00235	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—MDM2—ocular cancer	0.00235	0.00235	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—CDKN1B—ocular cancer	0.00232	0.00232	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—HRAS—ocular cancer	0.00225	0.00225	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—CDKN1A—ocular cancer	0.00224	0.00224	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—AKT1—ocular cancer	0.00223	0.00223	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—AKT1—ocular cancer	0.00223	0.00223	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—CDKN1B—ocular cancer	0.00215	0.00215	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—CDKN1A—ocular cancer	0.00214	0.00214	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—AKT1—ocular cancer	0.00211	0.00211	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—AKT1—ocular cancer	0.00208	0.00208	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—HRAS—ocular cancer	0.00207	0.00207	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—AKT1—ocular cancer	0.00199	0.00199	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—CDKN1A—ocular cancer	0.00198	0.00198	CbGpPWpGaD
Auranofin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	0.00198	0.00198	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—AKT1—ocular cancer	0.00191	0.00191	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SAG—ocular cancer	0.00188	0.00188	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MYC—ocular cancer	0.00185	0.00185	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TGFB1—ocular cancer	0.00185	0.00185	CbGpPWpGaD
Auranofin—ALB—Metabolism—PSPH—ocular cancer	0.00179	0.00179	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—TGFB1—ocular cancer	0.00177	0.00177	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MDM2—ocular cancer	0.00173	0.00173	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—E2F5—ocular cancer	0.00166	0.00166	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—HRAS—ocular cancer	0.00164	0.00164	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—E2F4—ocular cancer	0.00163	0.00163	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RBL1—ocular cancer	0.0016	0.0016	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CDKN1B—ocular cancer	0.00158	0.00158	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—ocular cancer	0.00152	0.00152	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—HRAS—ocular cancer	0.00151	0.00151	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	0.00149	0.00149	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—ocular cancer	0.00146	0.00146	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CDKN1A—ocular cancer	0.00146	0.00146	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—AKT1—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	0.00139	0.00139	CbGpPWpGaD
Auranofin—ALB—Hemostasis—GNA11—ocular cancer	0.00139	0.00139	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—E2F3—ocular cancer	0.00138	0.00138	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—AKT1—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Auranofin—ALB—Hemostasis—GNAQ—ocular cancer	0.00129	0.00129	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—HRAS—ocular cancer	0.00129	0.00129	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ocular cancer	0.00129	0.00129	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TFDP1—ocular cancer	0.00129	0.00129	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—AKT1—ocular cancer	0.00128	0.00128	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.00123	0.00123	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HDAC1—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—AKT1—ocular cancer	0.00114	0.00114	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAML2—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MDM2—ocular cancer	0.000987	0.000987	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HRAS—ocular cancer	0.000965	0.000965	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—HRAS—ocular cancer	0.000949	0.000949	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—MDM2—ocular cancer	0.000947	0.000947	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CDKN1B—ocular cancer	0.000901	0.000901	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GNA11—ocular cancer	0.000892	0.000892	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDKN1B—ocular cancer	0.000865	0.000865	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—AKT1—ocular cancer	0.000838	0.000838	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CDKN1A—ocular cancer	0.000831	0.000831	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GNAQ—ocular cancer	0.000829	0.000829	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CDK2—ocular cancer	0.000827	0.000827	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDKN1A—ocular cancer	0.000798	0.000798	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EP300—ocular cancer	0.000791	0.000791	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.000783	0.000783	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HDAC1—ocular cancer	0.000747	0.000747	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN2B—ocular cancer	0.00067	0.00067	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—E2F1—ocular cancer	0.000615	0.000615	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MDM2—ocular cancer	0.000575	0.000575	CbGpPWpGaD
Auranofin—ALB—Metabolism—GNA11—ocular cancer	0.000564	0.000564	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000544	0.000544	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HRAS—ocular cancer	0.000541	0.000541	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDKN1B—ocular cancer	0.000525	0.000525	CbGpPWpGaD
Auranofin—ALB—Metabolism—GNAQ—ocular cancer	0.000524	0.000524	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HRAS—ocular cancer	0.00052	0.00052	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDKN1A—ocular cancer	0.000484	0.000484	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AKT1—ocular cancer	0.000478	0.000478	CbGpPWpGaD
Auranofin—ALB—Hemostasis—EP300—ocular cancer	0.000464	0.000464	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EP300—ocular cancer	0.000461	0.000461	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—AKT1—ocular cancer	0.000459	0.000459	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000423	0.000423	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TGFB1—ocular cancer	0.000404	0.000404	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MDM2—ocular cancer	0.000372	0.000372	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN1B—ocular cancer	0.000339	0.000339	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—ocular cancer	0.000332	0.000332	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCND1—ocular cancer	0.000324	0.000324	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HRAS—ocular cancer	0.000318	0.000318	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HRAS—ocular cancer	0.000315	0.000315	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN1A—ocular cancer	0.000313	0.000313	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EP300—ocular cancer	0.000298	0.000298	CbGpPWpGaD
Auranofin—ALB—Hemostasis—AKT1—ocular cancer	0.000281	0.000281	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT1—ocular cancer	0.000278	0.000278	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MYC—ocular cancer	0.00026	0.00026	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TGFB1—ocular cancer	0.000259	0.000259	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—ocular cancer	0.000213	0.000213	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HRAS—ocular cancer	0.000204	0.000204	CbGpPWpGaD
Auranofin—ALB—Metabolism—EP300—ocular cancer	0.000188	0.000188	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT1—ocular cancer	0.00018	0.00018	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKT1—ocular cancer	0.000114	0.000114	CbGpPWpGaD
